Business Context and Reporting Period
Company: Assembly Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 24, 2016
Reporting Period: Single event date (February 24, 2016)
This filing serves as a Regulation FD disclosure to furnish an investor presentation to the public. The presentation is intended for use in meetings with investors and others commencing on the report date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute an investor presentation (Exhibit 99.1) rather than a financial statement report.
Material Changes
No material changes to financial performance or operations are reported in the text of this filing. The primary event is the release of the February 2016 Investor Presentation.
Guidance, Outlook, and Risks
Management Commentary: The Company is furnishing an investor presentation attached as Exhibit 99.1. This material is available on the Company's website.
Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is deemed "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Assembly Biosciences, Inc. Investor Presentation February 2016) for specific financial data and strategic outlook.
- Verify the availability of the presentation on the Company's investor relations website.
- Note that the content of the presentation is not legally "filed" with the SEC and carries different liability standards than standard financial reports.